IWR-1, a tankyrase inhibitor, attenuates Wnt/beta-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft

Author(s):
Martins-Neves, S.R.; Paiva-Oliveira, D.I.; Fontes-Ribeiro, C.; Bovee, J.V.M.G. (0000-0003-1155-0481); Cleton-Jansen, A.M.; Gomes, C.M.F.
Published
2018
Publication type
Article / Letter to editor
Cancer stem-like cellsOsteosarcomaWnt/beta-catenin signalingApoptosisIWR-1Doxorubicin
Date issued
2018-02-01
Language
English
Is part of
Cancer Letters (2018), Vol. 414, p. 1-15
hdl
1887/116245
doi
10.1016/j.canlet.2017.11.004